IMAGEMEND brings together a consortium of European scientists with extensive experience that is ideally suited for its neuroimaging and multi-modal investigations into psychiatric illnesses and subsequent clinical translation as diagnostic and predictive tests. The consortium includes 14 partners from 4 EU and 3 EU-associated countries. The EU partners in the project come from Germany, Italy, Netherlands and the UK and the remaining partners from Iceland, Norway and Switzerland. All IMAGEMEND partners are internationally renowned research institutions with distinguished track records in psychiatric neuroimaging and genetics and continue their existing, successful collaboration in the proposed project.